Compugen Ltd (CGEN)

NASDAQ

$2.33

$-0.04

(-1.68%)

Regular Market

Compugen Ltd (CGEN) Live Price Chart

Last updated: ⁦2026-09-28 18:22:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Compugen Ltd (CGEN) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $2.33, with a market capitalisation of $225.45M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.38 to $3.24. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$225.45M
Open	$2.34
Day's High	$19.90
Day's Low	$0.34
Previous Close	$2.38
Volume	67.63K
Average Volume	264.58K
P/E Ratio	--
52-Week High	$3.24
52-Week Low	$1.38
Dividend Yield	--
Earnings Date	--

Compugen Ltd (CGEN) Stock Price Today

Compugen Ltd (CGEN) is currently trading at $2.33 as of 2026-09-28 18:21:00, down 2.10% ($0.05) from the previous close of $2.38

During today's regular trading session, CGEN has traded between $0.34 and $19.90, with a trading volume of 67.63K shares. The current price is near the lower end of today's range.

Compugen Ltd (CGEN) 7-Day Stock Price Change

Over the past seven days, Compugen Ltd (CGEN) moved from $2.46 to $2.33, representing a decline of 5.28% ($0.13).

The stock traded between $2.31 and $2.50 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 168.08 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

CGEN 52-Week Price Position

Position in Range: 51.2%

52W Low$1.38

52W High$3.24

CGEN is currently trading at $2.33, placing it 51.2% of the way from its 52-week low of $1.38 to its 52-week high of $3.24. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Compugen Ltd (CGEN)?

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.

Compugen Ltd Information

Employees	75
Exchange	NASDAQ
Company Website	https://www.cgen.com

How to Buy Compugen Ltd (CGEN) Stock on MEXC

Eligible investors can buy real shares of Compugen Ltd (CGEN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CGEN and Place Your Order

Open the RealStocks trading page and search for CGEN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Compugen Ltd (CGEN) share price today?

Compugen Ltd (CGEN) is currently trading at $ 2.33, down 2.10% ($0.05) from the previous close of $ 2.38. Intraday prices update in real time during regular trading hours.

2.Is CGEN stock going up or down today?

As of 2026-09-28 18:21:00, CGEN is trading at $ 2.33, down 2.10% ($0.05) from its previous close of $ 2.38. The stock has traded between $ 0.34 and $ 19.90 during today’s regular session. Past price movements do not guarantee future results.

3.What is CGEN pre-market price?

As of 2026-09-28 18:21:00, CGEN is trading at $ 2.37 in pre-market trading, down 0.42% ($0.01) from the previous close of $ 2.38. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CGEN after-hours price?

As of 2026-09-28 18:21:00, CGEN is trading at $ 2.38 in after-hours trading, down 0.17% ($0.00) from the regular-session close of $ 2.38. After-hours prices may differ from the regular session's opening price due to lower liquidity and wider bid-ask spreads.

5.Is CGEN stock trading now?

CGEN trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CGEN sit relative to its 52-week high and low?

Over the past 52 weeks, CGEN has traded between a low of $ 1.38 and a high of $ 3.24. At $ 2.33, the stock is positioned 51.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Compugen Ltd in?

Compugen Ltd (CGEN) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Compugen Ltd's market capitalisation and where is it listed?

Compugen Ltd is listed on the NASDAQ exchange with a market capitalisation of $ 225.45M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CGEN valued in terms of P/E ratio and EPS?

CGEN trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Compugen Ltd pay a dividend?

Compugen Ltd pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.